SunWay Biotech Co., LTD. (TPEX:1271)
Taiwan · Delayed Price · Currency is TWD 59.10
+0.20 (0.34%)
Jul 30, 2026, 9:51 AM CST
SunWay Biotech Co., LTD. Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 3,557 | 3,587 | 4,728 | 4,568 | 1,598 | 2,041 | |
Market Cap Growth | -18.19% | -24.14% | 3.52% | 185.85% | -21.71% | - |
Enterprise Value | 4,143 | 3,452 | 4,693 | 4,567 | 1,154 | 1,698 |
Last Close Price | 58.12 | 59.40 | 76.55 | 128.32 | 42.69 | 51.23 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 35.06 | 35.34 | 39.88 | 99.10 | 53.19 | 12.10 |
PS Ratio | 3.58 | 3.61 | 4.87 | 8.00 | 3.76 | 5.37 |
PB Ratio | 1.09 | 1.10 | 1.45 | 1.43 | 5.55 | 3.73 |
P/TBV Ratio | 4.02 | 4.06 | 5.60 | 6.14 | 5.89 | 3.84 |
P/FCF Ratio | 29.34 | 29.59 | 116.10 | 468.66 | 37.52 | 13.51 |
P/OCF Ratio | 15.96 | 16.09 | 30.13 | 81.59 | 37.52 | 12.70 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 4.17 | 3.48 | 4.84 | 8.00 | 2.71 | 4.46 |
EV/EBITDA Ratio | 21.38 | 22.58 | 24.94 | 71.61 | 26.09 | 9.59 |
EV/EBIT Ratio | 33.29 | 33.15 | 33.29 | 87.67 | 29.41 | 10.15 |
EV/FCF Ratio | 34.17 | 28.47 | 115.23 | 468.61 | 27.09 | 11.24 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.27 | 0.27 | 0.08 | 0.09 | 0.25 | 0.01 |
Debt / EBITDA Ratio | 5.10 | 5.10 | 1.09 | 3.79 | 1.56 | 0.01 |
Debt / FCF Ratio | 7.30 | 7.30 | 5.99 | 29.48 | 1.67 | 0.02 |
Net Debt / Equity Ratio | 0.18 | 0.18 | -0.01 | -0.02 | -0.18 | -0.63 |
Net Debt / EBITDA Ratio | 3.82 | 3.82 | -0.26 | -1.17 | -1.19 | -1.94 |
Net Debt / FCF Ratio | 4.81 | 4.81 | -1.22 | -7.68 | -1.23 | -2.28 |
Asset Turnover | 0.24 | 0.24 | 0.26 | 0.27 | 0.78 | 0.68 |
Inventory Turnover | 2.16 | 2.16 | 2.24 | 2.53 | 3.22 | 1.31 |
Quick Ratio | 1.20 | 1.20 | 2.65 | 3.09 | 1.57 | 7.40 |
Current Ratio | 1.62 | 1.62 | 3.69 | 4.00 | 2.36 | 8.72 |
Return on Equity (ROE) | 3.11% | 3.11% | 3.67% | 2.64% | 7.51% | 33.55% |
Return on Assets (ROA) | 1.58% | 1.58% | 2.34% | 1.54% | 4.52% | 18.69% |
Return on Invested Capital (ROIC) | 2.38% | 2.59% | 3.71% | 2.56% | 14.15% | 89.01% |
Return on Capital Employed (ROCE) | 2.60% | 2.60% | 4.00% | 1.50% | 13.50% | 30.60% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 2.85% | 2.83% | 2.51% | 1.01% | 1.88% | 8.27% |
FCF Yield | 3.41% | 3.38% | 0.86% | 0.21% | 2.67% | 7.40% |
Dividend Yield | 1.68% | 1.68% | 1.74% | 0.77% | 7.46% | 8.35% |
Payout Ratio | 79.13% | 79.13% | 50.09% | 92.54% | 21.42% | 54.95% |
Buyback Yield / Dilution | 0.23% | 0.22% | -97.22% | -51.54% | 41.13% | -5.76% |
Total Shareholder Return | 1.91% | 1.91% | -95.48% | -50.77% | 48.59% | 2.59% |